Log In
Print this Print this

BAY 1097761

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionPegylated adrenomedullin
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase I
Standard Indication Pulmonary (unspecified)
Indication DetailsTreat lung disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today